Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
PMID: 21629200
For best results, use alongside a healthy diet, regular physical activity, adequate hydration, and positive lifestyle habits
Key secondary outcome measures from Boehringer Ingelheim's Phase II trial included: At least 30 percent relative reduction in liver fat content after 48 weeks of treatment compared to baseline Absolute and relative change of liver fat content from baseline after 48 weeks of treatment Improvement of fibrosis, defined as at least one stage decrease in fibrosis stage after 48 weeks of treatment Absolute change from baseline in total score for Non-alcoholic Fatty Liver Disease Activity Score (NAS) after 48 weeks of treatment
It plays an essential role in the energy metabolism of animal and plant cells
Segment Guests Dr
